Cargando…

Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes

Systemically administered glucocorticoids constitute an essential part of the immunosuppressive regimen for transplant recipients, yet their known risks of causing hyperglycemia or posttransplant diabetes require close monitoring and minimisation of use, when possible, to prevent detrimental effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bøtker, Simon, Birn, Henrik, Øzbay, Lara Aygen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884167/ https://www.ncbi.nlm.nih.gov/pubmed/36718481 http://dx.doi.org/10.1155/2023/3648178

Ejemplares similares

Posttransplant Intrarenal Lymphangiectasia
por: Kord, Ali, et al.
Publicado: (2020)

Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
por: Ammari, Zaid, et al.
Publicado: (2018)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020)

Gamma-delta mycosis fungoides in a posttransplant patient
por: Bittar, Julie M., et al.
Publicado: (2020)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

A Case of Posttransplant Fibrillary Glomerulonephritis
por: Ammayappan, Shiva Kumar, et al.
Publicado: (2023)

Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass
por: Arasaratnam, Reuben J., et al.
Publicado: (2017)

Posttransplant Complications and Comorbidities
por: Danziger-Isakov, Lara, et al.
Publicado: (2018)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
por: Kanda-Kato, Madoka, et al.
Publicado: (2020)

COVID-19 in posttransplant patients—report of 2 cases
por: Huang, Jiaofeng, et al.
Publicado: (2020)

Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD
por: Sobash, Philip T., et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
por: Halula, Sarah E., et al.
Publicado: (2015)

Novel use of acitretin for posttransplant Grover’s disease and cutaneous graft versus host disease
por: Gupta, Neha, et al.
Publicado: (2023)

Posttransplant infections
por: Thomas, Beje, et al.
Publicado: (2019)

CEUS Retrograde Cystography Is Helpful in Percutaneous Drainage of Complex Posttransplant Lymphocele
por: Di Domenico, Stefano, et al.
Publicado: (2012)

Thymic Hyperplasia after Lung Transplantation Imitating Posttransplant Lymphoproliferative Disorder
por: Steger, Christina Maria, et al.
Publicado: (2011)

Postrenal Transplant Metastatic Colonic Neoplasm: Posttransplant Lymphoproliferative Disorder or Adenocarcinoma?
por: Lal, H., et al.
Publicado: (2017)

A case of bizarre posttransplant anti-glomerular basement membrane disease
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2019)

Recurrent, Multisubtype Posttransplant Lymphoproliferative Disorder Masquerading as Inflammatory Bowel Disease
por: Mussarat, Saad, et al.
Publicado: (2022)

A case report of oral sulfamethoxazole in the treatment of posttransplant Listeria monocytogenes meningitis
por: Ma, Yinrui, et al.
Publicado: (2023)

Crystal-Induced Lower GI Necrosis in a Posttransplant Recipient with Diverticular Disease
por: Kumaresan, Maithrayie, et al.
Publicado: (2023)

Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS
por: Hansen, Per Boye, et al.
Publicado: (2012)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
por: Malhotra, Bharat, et al.
Publicado: (2015)

Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient
por: Ghaziani, Tara T., et al.
Publicado: (2018)

Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation
por: Patel, Harsh D., et al.
Publicado: (2017)

Secondary Subcutaneous Rhizopus Infection in a Posttransplant Recipient with Calcific Uremic Arteriolopathy
por: Anandh, Urmila, et al.
Publicado: (2020)

Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Posttransplant Metabolic Syndrome
por: Siddiqui, M. Shadab, et al.
Publicado: (2012)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
por: Twist, Clare J., et al.
Publicado: (2013)

Renal Allograft Torsion: US and CT Imaging Findings of a Rare Posttransplant Complication
por: Dewan, Rohit, et al.
Publicado: (2016)

Late-Onset Posttransplant Lymphoproliferative Disorder Results in Jejunal Stricture Managed with Endoscopic Dilation
por: Park, Steven, et al.
Publicado: (2021)

Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation
por: Quach, Kevin, et al.
Publicado: (2021)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

Staged Hand-Assisted Bilateral Native Nephrectomy for Management of Posttransplant Polyuria in an Adult with Dent's Disease
por: Montero, Rosa M., et al.
Publicado: (2015)

Castleman's Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
por: Jha, Lokesh K., et al.
Publicado: (2018)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
por: Paydaş, Saime, et al.
Publicado: (2013)

Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis
por: Moinuddin, Irfan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uu18i85o0rodar03lso9og60h5